Literature DB >> 870126

A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake.

B Harper, I E Hughes.   

Abstract

1. In isolated hearts of rabbits, perfusion with (-)-noradrenaline (0.0059 to 5.9 micronM) resulted in chronotropic and inotropic responses and a shortening of the interval between peak atrial and peak ventricular tensions (the A-V contraction interval). No dysrhythmias developed but at higher concentrations (590 micronM) 2 out of 7 hearts developed dysrhythmias (extrasystoles). 2. Perfusion with the antidepressants amitriptyline or maprotiline (4.8 micronM) or mianserin (28.8 micronM) reduced ventricular force, did not change heart rate and only amitriptyline reduced atrial force and lengthened the A-V contraction interval. At 4.8 micronM mianserin produced only a marginal shortening of the A-V contraction interval. 3. At these concentrations no dysrhythmias developed but at higher concentrations (amitriptyline 8 micronM, maprotiline 8 micronM, mianserin 60 micronM) all the agents produced dysrhythmias involving an interference with atrio-ventricular synchronization. 4. In the presence of mianserin (4.8 micronM) perfusion with noradrenaline (0.0059 to 5.9 micronM) shortened the A-V contraction interval and did not produce dysrhythmias. In the presence of amitriptyline or maprotiline (4.8 micronM) or mianserin (28.8 micronM) the A-V contraction interval generally lengthened and most hearts developed dysrhythmias (usually involving interference with atrio-ventricular synchronization). 5. [3H]-(-)-Noradrenaline uptake in perfused rabbit hearts and in mouse isolated atria or vasa deferentia was inhibited by the antidepressants to a similar extent, amitriptyline being marginally most potent (molar potency taken as 1.0), maprotiline being less potent (1.5) and mianserin least potent (2.0)). 6. It is concluded that of these three antidepressants, mianserin is least cardiotoxic in this preparation and that the ability of these antidepressants to predispose to noradrenaline-induced dysrhythmias is not related to blockade of noradrenaline uptake.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870126      PMCID: PMC1667750          DOI: 10.1111/j.1476-5381.1977.tb07734.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Arrhythmias and inhibition of noradrenaline uptake caused by tricyclic antidepressants and chlorpromazine on the isolated perfused rabbit heart.

Authors:  N Barth; M Manns; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes.

Authors:  M Raiteri; F Angelini; A Bertollini
Journal:  J Pharm Pharmacol       Date:  1976-06       Impact factor: 3.765

3.  Cardiovascular effects of amitriptyline, nortriptyline, protriptyline and doxepin in conscious rabbits.

Authors:  E Elonen; M J Mattila; L Saarnivaara
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

4.  The effects of the tricyclic antidepressants desipramine, doxepin and iprindole on the isolated perfused rabbit heart.

Authors:  N Barth; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  A useful muscarinic parameter and the differential recording of atrial and ventricular tension in the perfused rabbit heart.

Authors:  J R Fozard; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

6.  Propranolol in the treatment of cardiac arrhythmias associated with amitriptyline intoxication.

Authors:  R J Roberts; S Mueller; R M Lauer
Journal:  J Pediatr       Date:  1973-01       Impact factor: 4.406

7.  Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).

Authors:  T M Itil; N Polvan; W Hsu
Journal:  Curr Ther Res Clin Exp       Date:  1972-07

8.  Correlation of subjective side effects with plasma concentrations of nortriptyline.

Authors:  M Asberg; B Cronholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1970-10-03

9.  Interactions between sympathomimetic amines and antidepressant agents in man.

Authors:  A J Boakes; D R Laurence; P C Teoh; F S Barar; L T Benedikter; B N Prichard
Journal:  Br Med J       Date:  1973-02-10

10.  Cardiac complications during treatment with imipramin (Tofranil).

Authors:  E S Kristiansen
Journal:  Acta Psychiatr Scand       Date:  1961       Impact factor: 6.392

View more
  14 in total

1.  Effects of antidepressants on the intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarction.

Authors:  M Nishimoto; H Hashimoto; T Ozaki; S Nagashima; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

2.  Poisoning with antidepressants.

Authors:  H Kopera; H Schenk
Journal:  Br Med J       Date:  1977-09-17

Review 3.  Efficacy and side effects of mianserin, a tetracyclic antidepressant.

Authors:  A Wakeling
Journal:  Postgrad Med J       Date:  1983-04       Impact factor: 2.401

4.  Presynaptic alpha-adrenoceptor blocking properties among tri- and tetra-cyclic antidepressant drugs.

Authors:  B Harper; I E Hughes
Journal:  Br J Pharmacol       Date:  1979-12       Impact factor: 8.739

5.  Relative toxicity of amitriptyline, imipramine, maprotiline and mianserin after intravenous infusion in conscious rabbits.

Authors:  I E Hughes; S Radman
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

6.  Mianserin: a decade of scientific development.

Authors:  M Peet; H Behagel
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

Review 7.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

8.  The relative toxicity of amitriptyline, imipramine, maprotiline and mianserin in rabbits in vivo.

Authors:  I E Hughes; S Radwan
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

9.  Comparative electrophysiological effects of the antidepressants fluvoxamine and amitriptyline in the canine heart after myocardial infarction.

Authors:  Y Ikeda; M Nishimoto; Y Shimazu; H Hashimoto; K Umemura; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

10.  Interaction between mianserin and clonidine at alpha 2-adrenoceptors.

Authors:  Y Pommier; M Andréjak; P Mouillé; H Dabiré; B Lucet; H Schmitt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.